{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:27:39Z","timestamp":1792704459480,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.esmoop.2025.105805","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:18:22Z","timestamp":1759303102000},"page":"105805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4085-0741","authenticated-orcid":false,"given":"K.","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Owaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4987-1934","authenticated-orcid":false,"given":"I.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2173-5510","authenticated-orcid":false,"given":"M.","family":"Ishizaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Okemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-0015","authenticated-orcid":false,"given":"Y.","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4097-6120","authenticated-orcid":false,"given":"U.","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8646-3094","authenticated-orcid":false,"given":"K.","family":"Seguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hosokai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kuboki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2554-8334","authenticated-orcid":false,"given":"T.","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0044-953X","authenticated-orcid":false,"given":"T.","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-3630","authenticated-orcid":false,"given":"K.","family":"Shitara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10389","key":"10.1016\/j.esmoop.2025.105805_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.esmoop.2025.105805_bib2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105805_bib3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJMc2409512","article-title":"Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma","volume":"391","author":"Shitara","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2025.105805_bib4","author":"Lordick"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105805_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jphs.2024.08.005","article-title":"Effect of antiemetics on zolbetuximab-induced gastric injury and emesis in ferrets","volume":"156","author":"Kinugasa","year":"2024","journal-title":"J Pharmacol Sci"},{"issue":"9742","key":"10.1016\/j.esmoop.2025.105805_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105805_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0028-1098086","article-title":"An endoscopic recognition of the atrophic border and its significance in chronic gastritis","volume":"1","author":"Kimura","year":"1969","journal-title":"Endoscopy"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105805_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10120-025-01607-9","article-title":"Zolbetuximab-related gastritis: a case report of the patient with prolonged gastrointestinal symptoms","volume":"28","author":"Sugiyama","year":"2025","journal-title":"Gastric Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105805_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","article-title":"Claudin 18.2 as a novel therapeutic target","volume":"21","author":"Nakayama","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"23","key":"10.1016\/j.esmoop.2025.105805_bib12","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105805_bib13","doi-asserted-by":"crossref","first-page":"G1106","DOI":"10.1152\/ajpgi.00158.2007","article-title":"Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance","volume":"293","author":"Jovov","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105805_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/j.gastro.2011.10.040","article-title":"Deficiency of claudin-18 causes paracellular H+ leakage, up-regulation of interleukin-1\u03b2, and atrophic gastritis in mice","volume":"142","author":"Hayashi","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105805_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2013.11.022","article-title":"Expression of claudin-7 and loss of claudin-18 correlate with poor prognosis in gastric cancer","volume":"12","author":"Jun","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.esmoop.2025.105805_bib16","first-page":"3205","article-title":"Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105805_bib17","first-page":"377","article-title":"Up-regulated claudin 7 expression in intestinal-type gastric carcinoma","volume":"18","author":"Park","year":"2007","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105805_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10120-019-01014-x","article-title":"Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer","volume":"23","author":"Kohmoto","year":"2020","journal-title":"Gastric Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105805_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00428-019-02624-7","article-title":"Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study","volume":"475","author":"Dottermusch","year":"2019","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105805_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41416-019-0508-4","article-title":"Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases","volume":"121","author":"Coati","year":"2019","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105805_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104000","article-title":"Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer","volume":"9","author":"Kim","year":"2024","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105805_bib22","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/jpm11111095","article-title":"Association of CLDN18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas","volume":"11","author":"Pellino","year":"2021","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105805_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100762","article-title":"Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer","volume":"8","author":"Kubota","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.esmoop.2025.105805_bib24","article-title":"Retrospective study of Claudin 18 isoform 2 prevalence and prognostic association in gastric and gastroesophageal junction adenocarcinoma","volume":"8","author":"Waters","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105805_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.768","article-title":"The correlation of Th22 and regulatory T cells with Helicobacter pylori infection in patients with chronic gastritis","volume":"11","author":"Yao","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.esmoop.2025.105805_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.micpath.2017.06.040","article-title":"Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection","volume":"110","author":"Bagheri","year":"2017","journal-title":"Microb Pathog"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105805_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/jjco\/hyaf055","article-title":"Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer","volume":"55","author":"Yanagimoto","year":"2025","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.esmoop.2025.105805_bib28","article-title":"A case of gastritis developing in a patient receiving zolbetuximab-containing chemotherapy for CLDN18.2-positive advanced gastric cancer","volume":"9","author":"Ishizaka","year":"2025","journal-title":"ESMO Gastrointest Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925016746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925016746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:00:33Z","timestamp":1772895633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925016746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2059702925016746"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105805","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"105805"}}